指南与共识神经核医学

EANM实践指南:癫痫患者PET与SPECT的合理使用

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.
指南 / 共识 · Eur J Nucl Med Mol Imaging · 2024-02-23

耐药局灶性癫痫可考虑手术。该EANM指南旨在阐明放射性示踪剂成像在癫痫中的作用与挑战、规范分子影像操作流程,并基于现有文献提供特定临床情境下选择最合适成像流程的算法,以促进儿童、青少年和成人局灶性癫痫术前评估中的优化成像。

要点

  • 局灶性癫痫最常见,耐药者手术可缓解或消除发作并改善生活质量。
  • EANM指南提供基于文献的成像流程选择算法,重点服务局灶性癫痫术前评估。

核心结论

  • 该EANM指南旨在帮助理解放射性示踪剂成像在癫痫中的作用与挑战,为实施不同分子影像流程提供实用信息,并基于现有文献提供特定临床情境下选择最合适成像流程的算法。

研究设计与样本

  • 本指南由欧洲核医学协会(EANM)撰写并授权,基于当前文献制定,聚焦儿童、青少年和成人局灶性癫痫的术前评估。
  • 指南面向核医学专业人员及神经科、神经生理、神经外科、精神科、心理科等参与癫痫管理的专科人员。

主要发现

  • 局灶性癫痫是最常见的癫痫类型;耐药局灶性癫痫可依据致痫灶定位选择手术,以缓解发作或实现无发作并改善生活质量。
  • 头皮视频/脑电图(EEG)遥测、结构与功能磁共振成像(MRI)是诊断与治疗管理的主要标准工具,SPECT与PET分子神经影像影响治疗决策。
  • 迄今尚无基于文献的核医学成像程序在癫痫中应用的实践推荐。

关键数值与推荐

  • 指南提供基于当前文献的算法,用于在特定临床情境下选择最合适的成像流程。
  • 指南信息应依据当地法律法规以及各种放射性药物和成像设备的可及性加以应用。

临床怎么用

  • 指南用于协助核医学专业人员及相关专科人员检测和解读癫痫发作起始区(SOZ),以支持进一步治疗决策,尤其针对儿童、青少年和成人局灶性癫痫的术前评估。
  • 实施分子影像流程时应结合当地法规及放射性药物与成像设备的可及性,原文未据此给出其他具体推荐。

局限性

  • 原文指出,迄今尚无基于文献的核医学成像程序在癫痫中应用的实践推荐。
  • 指南信息应依据当地法律法规以及各种放射性药物和成像 modalities 的可及性加以应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epilepsy is one of the most frequent neurological conditions with an estimated prevalence of more than 50 million people worldwide and an annual incidence of two million. Although pharmacotherapy with anti-seizure medication (ASM) is the treatment of choice, ~30% of patients with epilepsy do not respond to ASM and become drug resistant. Focal epilepsy is the most frequent form of epilepsy. In patients with drug-resistant focal epilepsy, epilepsy surgery is a treatment option depending on the localisation of the seizure focus for seizure relief or seizure freedom with consecutive improvement in quality of life. Beside examinations such as scalp video/electroencephalography (EEG) telemetry, structural, and functional magnetic resonance imaging (MRI), which are primary standard tools for the diagnostic work-up and therapy management of epilepsy patients, molecular neuroimaging using different radiopharmaceuticals with single-photon emission computed tomography (SPECT) and positron emission tomography (PET) influences and impacts on therapy decisions. To date, there are no literature-based praxis recommendations for the use of Nuclear Medicine (NM) imaging procedures in epilepsy. The aims of these guidelines are to assist in understanding the role and challenges of radiotracer imaging for epilepsy; to provide practical information for performing different molecular imaging procedures for epilepsy; and to provide an algorithm for selecting the most appropriate imaging procedures in specific clinical situations based on current literature. These guidelines are written and authorized by the European Association of Nuclear Medicine (EANM) to promote optimal epilepsy imaging, especially in the presurgical setting in children, adolescents, and adults with focal epilepsy. They will assist NM healthcare professionals and also specialists such as Neurologists, Neurophysiologists, Neurosurgeons, Psychiatrists, Psychologists, and others involved in epilepsy management in the detection and interpretation of epileptic seizure onset zone (SOZ) for further treatment decision. The information provided should be applied according to local laws and regulations as well as the availability of various radiopharmaceuticals and imaging modalities.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Traub-Weidinger T, Arbizu J, Barthel H, et al. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy. Eur J Nucl Med Mol Imaging. 2024. PMID: 38393374. doi:10.1007/s00259-024-06656-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。